Fanny Pommeret
Barts Health NHS Trust(GB)Université Paris-Saclay(FR)Institut Gustave Roussy(FR)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, COVID-19 and healthcare impacts, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Ovarian cancer diagnosis and treatment
Most-Cited Works
- → Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19(2020)906 cited
- → Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report(2020)343 cited
- → Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19(2020)299 cited
- → Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers(2021)165 cited
- → Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study(2021)134 cited
- → Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort(2020)118 cited
- → Time-Dependent COVID-19 Mortality in Patients With Cancer(2021)71 cited
- → Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study(2021)51 cited
- → Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis(2021)43 cited
- → Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies(2021)38 cited